Press & News

People are different and so is their cancer, patients should be treated individually.

New The power of precision, For Every Oncologist, Today

With IndiTreat, 2cureX makes the testing of chemotherapeutic agents on patient-derived microtumors an operational reality.

Latest News

2cureX has signed a distribution agreement with specialized diagnostic solutions leader Werfen, to distribute 2cureX products in Spain

Latest press and news

May 11

Press Releases Regulatory

Warrants of series TO1 were subscribed to approximately 96.75 percent and 2cureX AB receives approximately SEK 31.40 million.

May 6

Press Releases Regulatory

2cureX publishes the annual report for the fiscal year 2020

May 6

Press Releases Regulatory

2cureX offentliggör årsredovisning för räkenskapsåret 2020

Apr 24

Press Releases Regulatory

Correction of “Notice to attend the Annual General Meeting of 2cureX AB” issued on 23rd April 2021.

Apr 24

Press Releases Regulatory

Korrektion till ”Kallelse till årsstämma i 2cureX AB” utfärdad den 23 april 2021.

Apr 23

Press Releases Regulatory

Kallelse till årsstämma i 2cureX AB

Apr 23

Press Releases Regulatory

Notice to attend the Annual General Meeting of 2cureX AB

Apr 23

Press Releases Regulatory

Teckningskursen för utnyttjande av teckningsoptioner av serie TO1 i 2cureX AB har fastställts till 13,22 SEK och teckningsperioden inleds den 26 april 2021